CEO, OmRx Oncology; CEO
Isy Goldwasser is a seasoned executive in the biotechnology and life sciences sectors, currently serving as chief executive officer at OmRx Oncology and Calibr BioVentures. Isy’s previous roles include entrepreneur-in-residence at Scripps Research, co-founder and CEO of thync, entrepreneur-in-residence at Khosla Ventures and CEO of Symyx Technologies, where he was the company’s first employee. He is a named inventor on more than 30 U.S., European and Canadian patents. Isy holds a Master of Science degree from Stanford University and a Bachelor of Science in chemical engineering from the Massachusetts Institute of Technology.